Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2012
07/12/2012WO2012053718A9 Method for inducing differentiation of adult stem cells and nerve cells using magnetic field
07/12/2012WO2012052872A9 Methods and compositions for the treatment of insulin-associated medical conditions
07/12/2012WO2012014207A3 Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
07/12/2012WO2011150055A3 Methods, substrates, and systems useful for cell seeding of medical grafts
07/12/2012WO2009152529A8 Programming and reprogramming of cells
07/12/2012US20120180168 Method for producing double haploid plants
07/12/2012US20120180166 Methods for producing transgenic plants
07/12/2012US20120180164 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
07/12/2012US20120180163 Woody plants having improved growth characteristics and method for making the same
07/12/2012US20120180161 Method of Modifying the Carbohydrate Content of a Plant
07/12/2012US20120180159 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases
07/12/2012US20120180157 Isolation and targeted suppression of lignin biosynthetic genes
07/12/2012US20120180156 Genes homologous to the flowering locus t (ft) gene and the use thereof for modulating tuberization
07/12/2012US20120180155 Cotton variety 09r532b2r2
07/12/2012US20120180154 Cotton variety 10r052b2r2
07/12/2012US20120180153 Cotton variety 09r536b2r2
07/12/2012US20120180152 Bean line ex 08071301
07/12/2012US20120180149 Double mutant mouse and cell lines
07/12/2012US20120180147 Microrna-24
07/12/2012US20120180142 Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
07/12/2012US20120180141 Transgenic Animal Models of Disease
07/12/2012US20120179139 Delivery System for Cell-Based Therapies
07/12/2012US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB
07/12/2012US20120178911 Genes with es cell-specific expression
07/12/2012US20120178801 Compositions and its use in treating obesity or inducing weight loss
07/12/2012US20120178796 Splice variants
07/12/2012US20120178783 Hdac inhibitors
07/12/2012US20120178751 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
07/12/2012US20120178749 Ns1 protein inhibitors
07/12/2012US20120178725 Method of modulating ship activity
07/12/2012US20120178719 Modulation of phospholipase d for the treatment of neurodegenerative disorders
07/12/2012US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production
07/12/2012US20120178693 Cofactors for Thrombin Activation of Factor VII and Uses Thereof
07/12/2012US20120178691 Factor viii compositions and methods of making and using same
07/12/2012US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178647 Engineering of zinc finger arrays by context-dependent assembly
07/12/2012US20120178628 Mutated acetohydroxyacid synthase genes in brassica
07/12/2012US20120178168 Method for regulating protein function in cells using synthetic small molecules
07/12/2012US20120178166 Simplified basic media for human pluripotent cell culture
07/12/2012US20120178165 Polymeric coatings and methods for forming them
07/12/2012US20120178164 Treating cardiovascular tissue
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178162 Polymer matrices for cell culture
07/12/2012US20120178161 Medium and culture of embryonic stem cells
07/12/2012US20120178160 Cultivation Of Primate Embryonic Stem Cells
07/12/2012US20120178159 Mesenchymal stem cells (msc) expansion methods and materials
07/12/2012US20120178158 Adult animals generated from induced pluripotent cells
07/12/2012US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/12/2012US20120178141 Luciferases and methods for making and using the same
07/12/2012US20120178127 Nucleic acid encoding apoptotic anti-ige antibodies
07/12/2012US20120178126 Methods and materials for increasing expression of recombinant polypeptides
07/12/2012US20120178116 Polypeptides for identifying fungicidally active compounds
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120178097 Methods and design of membrane filters
07/12/2012US20120178095 Cardiomyocyte differentiation
07/12/2012US20120177749 Family of pfkfb3 inhibitors with anti-neoplastic activities
07/12/2012US20120177724 Lipid vesicle compositions and methods of use
07/12/2012US20120177723 SiRNA PHOSPHOLIPID CONJUGATE
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177689 Generation of novel bone forming cells (monoosteophils) from ll-37 treated monocytes
07/12/2012US20120177677 Antigen specific multi epitope-based anti-infective vaccines
07/12/2012US20120177676 Alphabodies for hiv entry inhibition
07/12/2012US20120177675 Chimaeric Protein
07/12/2012US20120177673 Immunity-inducing agent
07/12/2012US20120177672 Therapeutic peptides, polypeptides and nucleic acid sequences
07/12/2012US20120177669 Phosphopeptides as melanoma vaccines
07/12/2012US20120177661 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
07/12/2012US20120177659 Methods and compositions for treating and diagnosing diseases
07/12/2012US20120177658 Methods of treatment using an anti il b50 antibody
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177651 Antigen-binding proteins
07/12/2012US20120177644 Mesenchymal stem cell differentiation
07/12/2012US20120177643 Human cdr-grafted antibody and antibody fragment thereof
07/12/2012US20120177639 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
07/12/2012US20120177638 Antibodies to vla-1
07/12/2012US20120177637 Method for selecting a single cell expressing a heterogeneous combination of antibodies
07/12/2012US20120177630 Treatment of rett syndrome and other disorders
07/12/2012US20120177627 Upregulation of integrin linked kinase (ilk) to provide cardioprotective effects
07/12/2012US20120177618 Hematopoietic stromal progenitor cells and uses thereof
07/12/2012US20120177616 Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
07/12/2012US20120177615 Tissue preservation system
07/12/2012US20120177614 Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural/progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro
07/12/2012US20120177611 Elastic substrates and methods of use in cell manipulation and culture
07/12/2012US20120177610 Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
07/12/2012US20120177601 Treatment of hepatitis c virus infections
07/12/2012US20120177597 Compositions and methods of alteration of autoimmune diseases
07/12/2012US20120177595 Multimeric il-15 soluble fusion molecules and methods of making and using same
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/12/2012US20120177566 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
07/12/2012DE102011008153A1 Preparing monoclonal antibody comprises immunizing mice with alpha synuclein peptide, removing and fusing B-lymphocytes with myeloma cell line, selecting fusion product peptide in cell culture vessel, selecting immunoglobulin and isolating
07/12/2012DE102011002536A1 Verpackung, enthaltend ein medizinisches Produkt zur Behandlung von menschlichen oder tierischen Knorpelschäden Package containing a medical product for the treatment of human or animal cartilage damage
07/12/2012CA2824643A1 Methods for enhancing the delivery of gene-transduced cells
07/12/2012CA2823639A1 High yield suspension cell line, system, and method for making same
07/12/2012CA2817765A1 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
07/11/2012EP2474611A1 Enhancer for promoter, and use thereof
07/11/2012EP2474610A1 Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa
07/11/2012EP2473598A2 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
07/11/2012EP2473530A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor
07/11/2012EP2473193A1 Methods of engineering neural tissue
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 1827